Yahoo! Finance: NVO News

Novo CEO Just Says "No" (at CNBC)

Tue, 15 Dec 2009 14:24:27 Etc/GMT

Eli Lillys Prognosis: Uncertainty (at Minyanville.com)

Thu, 10 Dec 2009 18:15:00 Etc/GMT

What happens when a patent cliff is within sight.

Investigating The FCPA (at Forbes.com)

Tue, 8 Dec 2009 18:06:24 Etc/GMT

ZGEN Inks Licensing Deal (Zacks.com)

Tue, 8 Dec 2009 13:02:22 Etc/GMT

Novo Nordisk Licenses IL-21 mAb and Patent Rights to IL-21 Antibodies from ZymoGenetics (Business Wire)

Tue, 8 Dec 2009 07:00:00 Etc/GMT

SEATTLE & COPENHAGEN----Novo Nordisk A/S and ZymoGenetics, Inc. today announced an agreement where Novo Nordisk in-licenses a fully-human anti-IL21 monoclonal antibody developed by ZymoGenetics, as well as broad intellectual property rights covering IL-21 mAb and the development of other IL-21 antibodies.

FDA Approves 10 mcg Dose of Vagifem(R) for the Treatment of Atrophic Vaginitis Due to Menopause (PR Newswire)

Wed, 2 Dec 2009 14:00:00 Etc/GMT

Novo Nordisk said today that the U.S. Food and Drug Administration has approved a 10 mcg dose formulation of Vagifem® for the treatment of atrophic vaginitis due to menopause - a condition experienced by up to 75 percent of postmenopausal women.

Increase In Patent Protection For Biologics Creates Significant Upside For Drug Development Enterprise Valuations (Wall Street Transcript)

Sat, 28 Nov 2009 15:31:00 Etc/GMT

67 WALL STREET, New York - November 28, 2009 - The Wall Street Transcript has recently published its Q4 2009 Biotechnology Report offering a timely review of the sector to serious investors and industry executives. This 70 page feature contains expert industry commentary through in-depth interviews with public company CEOs, Equity Analysts and Money Managers. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online.

Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows (PR Newswire)

Fri, 27 Nov 2009 14:30:00 Etc/GMT

The diabetes population in the United States will almost double over the next 25 years and annual medical spending on the disease is projected to hit $336 billion, up from $113 billion today, according to a study published in the December issue of Diabetes Care.

The Complete List of Danish ADR Stocks (at Seeking Alpha)

Fri, 20 Nov 2009 11:36:09 Etc/GMT

Doctors Cite Time, Low Reimbursement As Barriers To Providing Comprehensive Diabetes Care, Survey Results Show (PR Newswire)

Thu, 19 Nov 2009 13:00:00 Etc/GMT

Equipped to Provide Ideal, Multi-Disciplinary Team Care

Can This Stock Go Higher? (at Motley Fool)

Wed, 18 Nov 2009 18:56:27 Etc/GMT

Secure Your Future Forever With These Stocks (at Motley Fool)

Tue, 17 Nov 2009 21:04:33 Etc/GMT

Music to Health-Care Investors' Ears (at Motley Fool)

Mon, 16 Nov 2009 20:32:53 Etc/GMT

International Healthcare Stock Picks From Natcan Investment Management (Wall Street Transcript)

Mon, 16 Nov 2009 18:00:00 Etc/GMT

67 WALL STREET, New York - November 16, 2009 - The Wall Street Transcript has just published its Biotechnology Report offering a timely review of the sector to serious investors and industry executives. This 70 page feature contains expert industry commentary through in-depth interviews with public company CEOs, Equity Analysts and Money Managers. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online.

For Big Pharma, Diabetes Means Big Business (at Minyanville.com)

Fri, 13 Nov 2009 19:55:00 Etc/GMT

Treating the disease is 12% of the worlds health-care expenditure.

Piper Jaffray Senior Research Analyst Sees M&A Activity As Brisk As Foreign Companies Seek US Specialty Pharmaceutical Distribution Networks (Wall Street Transcript)

Fri, 13 Nov 2009 14:06:00 Etc/GMT

67 WALL STREET, New York - November 13, 2009 - The Wall Street Transcript has just published its Pharmaceuticals Report offering a timely review of the sector to serious investors and industry executives. This 76 page feature contains expert industry commentary through in-depth interviews with public company CEOs, Equity Analysts and Money Managers. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online.

This Drug Firm Will Snap Up 50% By Mid-2010: Trader (at CNBC)

Thu, 12 Nov 2009 13:00:31 Etc/GMT

Pharma's Future In Social Media (at Forbes.com)

Thu, 12 Nov 2009 01:08:00 Etc/GMT

Amylin To Live Large On The Fat Of The Land (at Forbes.com)

Thu, 5 Nov 2009 18:50:00 Etc/GMT

Shrugging Off the Side Effects (at Motley Fool)

Fri, 30 Oct 2009 20:00:27 Etc/GMT